Home / Eye care / Altris AI

Altris, Inc. (Chicago, US)

Altris AI

Browser software that analyses retinal OCT scans and, according to the provider, recognises 70+ biomarkers and pathologies, with severity scores for triage. Works with OCT devices from multiple brands and also targets optometrists.

Shared spot3of 14 professional tools with a GDPR profileOur summary of what the provider itself publishes about your data: whether the data is stored in the EU (2 points), whether there is a certification or GDPR safeguard (1) and whether the provider is established in the Netherlands or the EU (1). 3 or 4 points is Strong, 2 Good, 1 Limited, 0 Unknown. How we measure in eye care
GDPR: Limited
  • Provider based outside the EU
  • Publishes certification/GDPR safeguards

Each block is a professional tool in eye care, with the strongest GDPR profile on the left. 9 professional tools share this spot, just like Altris AI with a Limited profile. Click through for that tool.

Priceon request (2 weeks free trial)
Free trialNot foundNot found on the provider's site when checked on 30 October 2026
BasedChicago, USOutside the EU
ModelNot publicProprietary image model for OCT analysis, not a language model. CE mark (2019) and FDA 510(k); class not public. US provider that claims GDPR and HIPAA compliance; hosting not public: ask about EU hosting and transfers to the US.

Last checked: 30 October 2026 · How we check

Is this your tool? Fill in missing details

What it does

Detection of biomarkers and pathologies on OCT
Glaucoma risk via GCC and optic disc analysis
Triage with the severity cube
Tracking progression with charts and graphs
Flags: filter patients by biomarker
Analysis of historical OCT data
Customisable PDF reports
Works with OCT scanners from e.g. Zeiss and Topcon

Comparable in eye care

All 14 professional tools for eye care

Altris AI compared

Underlying model

proprietary image model for OCT analysis, not a language model. CE marking (2019) and FDA 510(k); class not public. US provider that claims GDPR and HIPAA compliance; hosting not public: ask about EU hosting and transfers to the US. Many tools build on a large model from, for example, OpenAI or Anthropic. If in doubt, ask for the data processing agreement: it states where your data goes.

GDPR check for eye care

Questions about Altris AI

Which AI model does Altris AI use?
The maker of Altris AI does not publish which AI model sits underneath. Own image model for OCT analysis, not a language model. CE marking (2019) and FDA 510(k); class not public. US provider claiming GDPR and HIPAA compliance; hosting not public: ask about EU hosting and transfers to the US.
How much does Altris AI cost?
on request (2 weeks free trial). Check the current price on the provider's website; prices change often.
Who is Altris AI for?
Altris AI focuses on eye care. It supports work such as taking and assessing retinal photographs and OCT scans, and storing them (fundus, OCT, visual field), screening for diabetic retinopathy, glaucoma and AMD with timely referral, monitoring patients with wet AMD and scheduling injection treatments.
What should I watch out for with AI in eye care?
Retinal images are health data and therefore special category personal data under the GDPR. Software that assesses images is a medical device: check the CE class under the MDR (usually IIa or IIb) and whether the algorithm has been validated for your camera or OCT device. Some tools are for 'research use only'. Choose a provider with a data processing agreement, ISO 27001 and ISO 13485, and clear data location (EU hosting or on-premise). Ask whether your images are used to train models. Opticians without a medical background may screen and refer, but not make a diagnosis. Explain in your client communication what an AI result does and does not mean. Under the EU AI Act, medical AI counts as high risk.

Every Friday: what changed in AI for eye care

New models, prices, oversight and tools, with sources and what it means for you. One email a week, unsubscribe with one click.

View a sample

We only use your address for this newsletter. You confirm first by email.